B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FEN1

MOLECULAR TARGET

flap structure-specific endonuclease 1

UniProt: P39748NCBI Gene: 223722 compounds

FEN1 (flap structure-specific endonuclease 1) is targeted by 22 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FEN1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1myricetin-3-O-galactopyranoside [Supplementary Concept]2.087
2Quercetin1.393
3Aurintricarboxylic Acid1.393
4Norepinephrine Precursor of epinephrine that is secreted by1.393
5Dequalinium1.102
6Diiodotyrosine1.102
7Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as1.102
8Epinephrine1.102
9Ethidium1.102
10Idarubicin1.102
11Levodopa1.102
12Methyldopa1.102
13piceatannol1.102
14Doxycycline0.691
15Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
16Methylene Blue0.691
17Carmine Coloring matter from0.691
18Cisplatin0.691
19Demeclocycline0.691
20Dithiazanine 3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3- pentadienyl)benzothiazolium.0.691
21Oxytetracycline0.691
22streptonigrin0.691

About FEN1 as a Drug Target

FEN1 (flap structure-specific endonuclease 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 22 compounds with documented FEN1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FEN1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.